UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

Alimentary Pharmacology & Therapeutics (Suppl), 2018-05, Vol.47 (10), p.1387-1396

2018

Volltextzugriff (PDF)

Non-invasive assessment of hepatic iron stores by MRI

The Lancet (British edition), 2004-01, Vol.363 (9406), p.357-362

2004

Volltextzugriff (PDF)

A double‐blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis

Hepatology (Baltimore, Md.), 2004-05, Vol.39 (5), p.1390-1397

2004

Volltextzugriff (PDF)

Prospective Validation of the Prognostic Usefulness of Brain Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Mitral Regurgitation

Journal of the American College of Cardiology, 2009-09, Vol.54 (12), p.1099-1106

2009

Volltextzugriff (PDF)

P1015 COMBINATION OF BLOOD MARKERS TARGETED FOR DIFFERENT FIBROSIS STAGES OUTPERFORMS LIVER BIOPSY FOR PROGNOSTICATION IN HEPATITIS C

Journal of hepatology, 2014-04, Vol.60 (1), p.S413-S413

2014

Volltextzugriff (PDF)

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (7), p.991-1003

2017

Volltextzugriff (PDF)

Prospective Validation of the Prognostic Usefulness of B-Type Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Aortic Regurgitation

Journal of the American College of Cardiology, 2011-10, Vol.58 (16), p.1705-1714

2011

Volltextzugriff (PDF)

Screening of large esophageal varices by a simple algorithm of blood markers

Journal of hepatology, 2017, Vol.66 (1), p.S565-S566

2017

Volltextzugriff (PDF)

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C

Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (2), p.178-188

2014

Volltextzugriff (PDF)

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C?

Journal of hepatology, 2017, Vol.66 (1), p.S669-S670

2017

Volltextzugriff (PDF)

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination?

Journal of hepatology, 2016, Vol.64 (2), p.S736-S737

2016

Volltextzugriff (PDF)

324 COMPARISON OF DIAGNOSTIC ALGORITHMS FOR LIVER FIBROSIS IN HEPATITIS C. NEW ALGORITHMS ARE AS EFFECTIVE WHILE MORE PRECISE AND TOTALLY NON-INVASIVE

Journal of hepatology, 2011-03, Vol.54, p.S130-S130

2011

Volltextzugriff (PDF)

Non-Invasive Tests for the Diagnosis of Liver Fibrosis are also Prognostic Markers in Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2016, Vol.64 (2), p.S484-S484

2016

Volltextzugriff (PDF)

The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease

Journal of hepatology, 2017, Vol.66 (1), p.S161-S162

2017

Volltextzugriff (PDF)

P1017 EVALUATION OF THE PROGNOSTIC VALUE OF NON-INVASIVE LIVER FIBROSIS TESTS TO PREDICT MORTALITY BY TIME-DEPENDENT ROC CURVES

Journal of hepatology, 2014-04, Vol.60 (1), p.S414-S414

2014

Volltextzugriff (PDF)

O77 PROGNOSTIC MODELS FOR MORTALITY USING THE SUCCESSIVE VALUES OF NON-INVASIVE FIBROSIS TESTS IN PATIENTS WITH CHRONIC LIVER DISEASE

Journal of hepatology, 2014-04, Vol.60 (1), p.S32-S32

2014

Volltextzugriff (PDF)

SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma

Journal of hepatology, 2017, Vol.66 (1), p.S85-S86

2017

Volltextzugriff (PDF)

P0509 : Diagnostic and prognostic stagings are improved by multi-targeting biomarkers. Application to liver fibrosis tests

Journal of hepatology, 2015-04, Vol.62, p.S505-S506

2015

Volltextzugriff (PDF)

P0511 : Direct comparison of 3 elastrometry devices (fibroscan, acoustic radiation force impulse, supersonic shearwave imaging) for the non-invasive diagnosis of liver fibrosis in chronic liver diseases

Journal of hepatology, 2015-04, Vol.62, p.S506-S506

2015

Volltextzugriff (PDF)

Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring

European radiology, 2009-08, Vol.19 (8), p.1991-1997

2009

Volltextzugriff (PDF)

A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S1-S1

2017

Volltextzugriff (PDF)

The Quick SOFA, a simple bedside score, identifies hospitalized cirrhotic patients with poor outcomes

Journal of hepatology, 2017, Vol.66 (1), p.S379-S380

2017

Volltextzugriff (PDF)

P0121 : Angiotensin II inhibition to treat severe liver fibrosis: A double-blind randomized trial (ANRS HC19)

Journal of hepatology, 2015-04, Vol.62, p.S346-S346

2015

Volltextzugriff (PDF)

122 NON-SELECTIVE BETA-BLOCKERS MIGHT DECREASE SURVIVAL IN SEVERE ALCOHOLIC CIRRHOSIS

Journal of hepatology, 2013-04, Vol.58, p.S54-S55

2013

Volltextzugriff (PDF)

712 EVALUATION OF CIRRHOSIS MISCLASSIFICATION RATE BY NON-INVASIVE TESTS IN HEPATITIS C TRIALS

Journal of hepatology, 2013-04, Vol.58, p.S289-S289

2013

Volltextzugriff (PDF)

1 – 25 von 461

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(337)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

Non-invasive assessment of hepatic iron stores by MRI

A double‐blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis

Prospective Validation of the Prognostic Usefulness of Brain Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Mitral Regurgitation

P1015 COMBINATION OF BLOOD MARKERS TARGETED FOR DIFFERENT FIBROSIS STAGES OUTPERFORMS LIVER BIOPSY FOR PROGNOSTICATION IN HEPATITIS C

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Prospective Validation of the Prognostic Usefulness of B-Type Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Aortic Regurgitation

Screening of large esophageal varices by a simple algorithm of blood markers

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C?

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination?

324 COMPARISON OF DIAGNOSTIC ALGORITHMS FOR LIVER FIBROSIS IN HEPATITIS C. NEW ALGORITHMS ARE AS EFFECTIVE WHILE MORE PRECISE AND TOTALLY NON-INVASIVE

Non-Invasive Tests for the Diagnosis of Liver Fibrosis are also Prognostic Markers in Non-Alcoholic Fatty Liver Disease

The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease

P1017 EVALUATION OF THE PROGNOSTIC VALUE OF NON-INVASIVE LIVER FIBROSIS TESTS TO PREDICT MORTALITY BY TIME-DEPENDENT ROC CURVES

O77 PROGNOSTIC MODELS FOR MORTALITY USING THE SUCCESSIVE VALUES OF NON-INVASIVE FIBROSIS TESTS IN PATIENTS WITH CHRONIC LIVER DISEASE

SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma

P0509 : Diagnostic and prognostic stagings are improved by multi-targeting biomarkers. Application to liver fibrosis tests

P0511 : Direct comparison of 3 elastrometry devices (fibroscan, acoustic radiation force impulse, supersonic shearwave imaging) for the non-invasive diagnosis of liver fibrosis in chronic liver diseases

Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring

A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis

The Quick SOFA, a simple bedside score, identifies hospitalized cirrhotic patients with poor outcomes

P0121 : Angiotensin II inhibition to treat severe liver fibrosis: A double-blind randomized trial (ANRS HC19)

122 NON-SELECTIVE BETA-BLOCKERS MIGHT DECREASE SURVIVAL IN SEVERE ALCOHOLIC CIRRHOSIS

712 EVALUATION OF CIRRHOSIS MISCLASSIFICATION RATE BY NON-INVASIVE TESTS IN HEPATITIS C TRIALS

Suchergebnisse filtern